#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pancreatic carcinoma metastatic Congenital disorder of glycosylation Polyneuropathy Infective uveitis Candida infection Metastases to central nervous system Osteomyelitis Rosai-Dorfman syndrome Rhabdoid tumour Erythema multiforme Aicardi-Goutieres syndrome Cutaneous T-cell lymphoma recurrent Congenital cystic kidney disease Iron overload Loss of consciousness More trials…

    Learn about Rare Diseases

    Usher’s syndrome – Basic Information Short-bowel syndrome – Treatment Antisynthetase syndrome – Treatment Primary hyperoxaluria – Treatment Castleman’s disease – Basic Information Angiosarcoma non-metastatic – Basic Information Hereditary motor and sensory neuropathy Cerebral arteriovenous malformation haemorrhagic Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    M2Rlab Ivospemin Propranolol Hydrochloride Ofloxacin Cemdisiran Cipaglucosidase Alfa Litenimod Sodium Hydroxycarbamide PHENTOLAMINE MESILATE Batoclimab Tozorakimab Oxybuprocaine Timrepigene Emparvovec Pritelivir Midodrine Hydrochloride Inclisiran Sodium Alxn1850 Human Plasma Protein SKB410 Venetoclax More therapies…

    Learn about Your Condition

    Hypertension Breast proliferative changes Sciatica Arteriosclerosis Acquired ATTR amyloidosis Renal cancer Shprintzen-Goldberg syndrome Aplastic anaemia Joint stabilisation Incontinence Haemodialysis Lennox-Gastaut syndrome Gout Laryngeal cancer stage II Implantation complication More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effects of Atorvastatin for Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Myeloproliferative neoplasm
    Investigated Drugs:
    • Atorvastatin
    Denmark

  • Study comparing venetoclax with intensive chemotherapy (daunorubicin, cytarabine, gemtuzumab ozogamicin) in patients with favorable risk acute myeloid leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Gemtuzumab Ozogamicin
    • Daunorubicin Hydrochloride
    • Cytarabine
    Denmark

  • Study on Early Drug Withdrawal in Children with Juvenile Idiopathic Arthritis Using Secukinumab and Drug Combination for Those in Clinical Remission

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Secukinumab
    • Abatacept
    • Etanercept
    Belgium Czechia Denmark Italy Lithuania Portugal +1

  • Study on Chemo-Immunotherapy with Avelumab for Patients with Locally Advanced Urothelial Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma
    Investigated Drugs:
    • Avelumab
    The Netherlands

  • Study Comparing ARI-0001 and Axicabtagene Ciloleucel for Patients with Relapsed or Refractory Non-Hodgkin Lymphoma

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Varnimcabtagene Autoleucel
    • Axicabtagene Ciloleucel
    The Netherlands

  • Study on the Effectiveness of Oxaliplatin, Docetaxel, and Fluorouracil in Patients with Resectable Gastric and Gastroesophageal Junction Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Adenocarcinoma gastric
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Calcium Folinate
    • Cisplatin
    • Docetaxel
    Germany
Previous Page
1 … 632 633 634 635 636 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!